U.S. PHARMACOPEIA

Search USP29  
Anticoagulant Citrate Phosphate Dextrose Solution
» Anticoagulant Citrate Phosphate Dextrose Solution is a sterile solution of Citric Acid, Sodium Citrate, Monobasic Sodium Phosphate, and Dextrose in Water for Injection. It contains, in each 1000 mL, not less than 2.11 g and not more than 2.33 g of monobasic sodium phosphate (NaH2PO4·H2O); not less than 24.22 g and not more than 26.78 g of dextrose (C6H12O6·H2O); not less than 19.16 g and not more than 21.18 g of total citrate, expressed as citric acid, anhydrous (C6H8O7); and not less than 6.21 g and not more than 6.86 g of Sodium (Na). It contains no antimicrobial agents.
Prepare Anticoagulant Citrate Phosphate Dextrose Solution as follows:
Citric Acid (anhydrous) 2.99 g
Sodium Citrate (dihydrate) 26.3 g
Monobasic Sodium Phosphate
(monohydrate; NaH2PO4·H2O)
2.22 g
Dextrose (monohydrate) 25.5 g
Water for Injection, a sufficient
quantity, to make
1000 mL
Dissolve the ingredients, and mix. Filter the solution until clear, place immediately in suitable containers, and sterilize.
If desired, 3.27 g of monohydrated citric acid may be used instead of the indicated amount of anhydrous citric acid; 23.06 g of anhydrous sodium citrate may be used instead of the indicated amount of dihydrated sodium citrate; 1.93 g of anhydrous monobasic sodium phosphate may be used instead of the indicated amount of monohydrated monobasic sodium phosphate; and 23.2 g of anhydrous dextrose may be used instead of the indicated amount of monohydrated dextrose.
Packaging and storage— Preserve in single-dose containers, of colorless, transparent, Type I or Type II glass, or of a suitable plastic material (see Transfusion and Infusion Assemblies and Similar Medical Devices 161).
Labeling— Label it to indicate the number of mL of Solution required per 100 mL of whole blood or the number of mL of Solution required per volume of whole blood to be collected.
Identification— It responds to the Identification test under Dextrose, and to the tests for Phosphate 191, and, when concentrated to one-half its volume, responds to the tests for Citrate 191 and for Sodium 191.
Bacterial endotoxins 85 It contains not more than 5.56 USP Endotoxin Units per mL.
pH 791: between 5.0 and 6.0.
Chloride 221 A 10-mL portion shows no more chloride than corresponds to 0.50 mL of 0.020 N hydrochloric acid (0.0035%).
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Other requirements— It meets the requirements under Injections 1.
Assay for total citrate—
Standard preparations— Dissolve a suitable quantity of citric acid, previously dried at 90 for 3 hours and accurately weighed, in water to obtain a stock solution having a known concentration of about 1.0 mg of anhydrous citric acid per mL. Pipet aliquots of 8, 9, 10, 11, and 12 mL, respectively, of the stock solution into separate 100-mL volumetric flasks, dilute with water to volume, and mix.
Assay preparation— Pipet 10 mL of Solution into a 100-mL volumetric flask, dilute with water to volume, and mix. Pipet 5 mL of this solution into another 100-mL volumetric flask, dilute with water to volume, and mix.
Procedure— Pipet 1 mL of the Assay preparation, each Standard preparation, and water into a suitable test tube. To each tube add 1.3 mL of pyridine, and mix by swirling. To one tube at a time add 5.7 mL of acetic anhydride, and mix, using a rotary vortex stirrer. Immediately place in a water bath maintained at 31 ± 1.0, and allow the color to develop for 33 ± 1 minutes. Determine the absorbance against the reference blank in 2.5-cm cells at 425 nm, taking care to measure the absorbance of each solution at the same elapsed time from mixing. Plot the absorbances of the Standard preparations versus the concentrations, and draw the straight line best fitting the plotted points. From the graph so obtained, calculate the total citrate content, in mg per mL, of the Anticoagulant Citrate Phosphate Dextrose Solution taken by the formula:
0.2C,
in which C is the concentration, in µg per mL, of anhydrous citric acid read from the standard curve.
Assay for total phosphate [expressed as monobasic sodium phosphate, monohydrate (NaH2PO4·H2O)]—
1 ,2,4-Aminonaphtholsulfonic acid solution—Dissolve 0.5 g of 1,2,4-aminonaphtholsulfonic acid in about 150 mL of sodium metasulfite solution (3 in 20) in a 200-mL volumetric flask, warming if necessary. Add 5 mL of sodium sulfite solution (1 in 5), mix, and dilute with sodium metasulfite solution (3 in 20) to volume.
Standard preparation— Dissolve about 0.44 g of monobasic potassium phosphate, accurately weighed, in water to make 1000 mL, and mix. Pipet 25 mL of this solution into a 100-mL volumetric flask, and dilute with water to volume so as to obtain a solution having a known concentration of about 0.11 mg per mL of monobasic potassium phosphate.
Assay preparation— Dilute 5.0 mL of Solution with water to 100 mL.
Procedure— Pipet 5 mL of Standard preparation, 5 mL of Assay preparation, and 5 mL of water, to provide a control, into separate 25-mL volumetric flasks. Treat the contents of each flask as follows. Add 10.0 mL of 1 N sulfuric acid, and mix. Add 2.0 mL of ammonium molybdate solution (1 in 40), and mix. Add 1.0 mL of 1,2,4-Aminonaphtholsulfonic acid solution, dilute with water to volume, again mix, and allow to stand for 10 minutes at 20 to 25. Determine the absorbances of the solutions from the Standard preparation and the Assay preparation against the reference solution in 1-cm cells at 660 nm, with a suitable spectrophotometer, taking care to measure the absorbance of each solution at the same elapsed time from mixing. Calculate the quantity, in mg, of monobasic sodium phosphate (NaH2PO4·H2O) in each mL of the Solution taken by the formula:
20.28C(AU / AS),
in which C is the concentration, in mg per mL, of KH2PO4 in the Standard preparation; and AU and AS are the absorbances of the solutions from the Assay preparation and the Standard preparation, respectively.
Assay for dextrose— Tare a clean, medium-porosity filtering crucible containing several carborundum boiling chips or glass beads. Pipet 50 mL of freshly mixed alkaline cupric tartrate TS into a 400-mL beaker. Add the boiling chips or glass beads from the tared crucible, 45 mL of water, and 5.0 mL of Solution to the beaker. Heat the beaker and contents over a burner that has been adjusted to cause boiling of the solution to start in 3.5 to 4 minutes. Boil the solution for 2 minutes, accurately timed, and filter immediately through the tared crucible, taking care to transfer all of the boiling chips or glass beads to the crucible. Wash the precipitate with hot water and 10 mL of alcohol. Dry the crucible and contents at 110 to constant weight. Perform a blank determination, and correct the weight of the precipitate from the sample for any precipitate obtained in the blank. Each mg of cuprous oxide precipitate obtained from the substance under assay is equivalent to 0.496 mg of C6H12O6·H2O.
Assay for sodium— Proceed as directed in the Assay for sodium under Anticoagulant Citrate Phosphate Dextrose Adenine Solution.
Auxiliary Information— Staff Liaison : Andrzej Wilk, Ph.D., Senior Scientific Associate
Expert Committee : (BBBBP05) Biologics and Biotechnology - Blood and Blood Products
USP29–NF24 Page 181
Pharmacopeial Forum : Volume No. 31(3) Page 730
Phone Number : 1-301-816-8305